| Edwin L Kelsey, MD | |
|
801 Princeton Ave Sw, Pob I Suite 201, Birmingham, AL 35211-1310 | |
| (205) 783-7705 | |
| (205) 352-4433 |
| Full Name | Edwin L Kelsey |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 36 Years |
| Location | 801 Princeton Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932106895 | NPI | - | NPPES |
| 529914300 | Medicaid | AL | |
| 1841352929 | Other | AL | GROUP NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 16871 (Alabama) | Secondary |
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 16871 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pain And Rehabilitation Center, Inc. | 0749174571 | 11 |
News Archive
GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.
Building on earlier clinical trials, UCLA researchers have confirmed that the "breakthrough" drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone.
Severe cases of COVID-19 can involve extensive inflammation in the body, and clinicians have wondered if this state is similar to what are called cytokine storm syndromes, in which the immune system produces too many inflammatory signals that can sometimes lead to organ failure and death.
Not long ago, organ transplantation was not considered an option for HIV infected patients.
› Verified 8 days ago
| Entity Name | Pain And Rehabilitation Center, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518065994 PECOS PAC ID: 0749174571 Enrollment ID: O20040211001096 |
News Archive
GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.
Building on earlier clinical trials, UCLA researchers have confirmed that the "breakthrough" drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone.
Severe cases of COVID-19 can involve extensive inflammation in the body, and clinicians have wondered if this state is similar to what are called cytokine storm syndromes, in which the immune system produces too many inflammatory signals that can sometimes lead to organ failure and death.
Not long ago, organ transplantation was not considered an option for HIV infected patients.
› Verified 8 days ago
| Entity Name | Birmingham Pain Management & Rehabilitation Centers, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841352929 PECOS PAC ID: 5799887634 Enrollment ID: O20070223000647 |
News Archive
GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.
Building on earlier clinical trials, UCLA researchers have confirmed that the "breakthrough" drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone.
Severe cases of COVID-19 can involve extensive inflammation in the body, and clinicians have wondered if this state is similar to what are called cytokine storm syndromes, in which the immune system produces too many inflammatory signals that can sometimes lead to organ failure and death.
Not long ago, organ transplantation was not considered an option for HIV infected patients.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edwin L Kelsey, MD 801 Princeton Ave Sw, Pob I Suite 201, Birmingham, AL 35211-1310 Ph: (205) 783-7705 | Edwin L Kelsey, MD 801 Princeton Ave Sw, Pob I Suite 201, Birmingham, AL 35211-1310 Ph: (205) 783-7705 |
News Archive
GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.
Building on earlier clinical trials, UCLA researchers have confirmed that the "breakthrough" drug palbociclib when used in combination with the traditional hormonal therapy letrozole delays progression of advanced breast cancer significantly and without the harsh side effects seen in some women prescribed letrozole alone.
Severe cases of COVID-19 can involve extensive inflammation in the body, and clinicians have wondered if this state is similar to what are called cytokine storm syndromes, in which the immune system produces too many inflammatory signals that can sometimes lead to organ failure and death.
Not long ago, organ transplantation was not considered an option for HIV infected patients.
› Verified 8 days ago
Charles R Law, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3944 Fax: 205-413-4914 | |
Keneshia Kirksey, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Charles Carnel, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 805 Saint Vincents Dr, Birmingham, AL 35205 Phone: 205-939-3699 Fax: 205-581-7155 | |
Lonnie Blake Dorcey, RPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1201 3rd Ave N Ste B, Birmingham, AL 35203 Phone: 256-546-8127 Fax: 256-547-6720 | |
Dr. Srinivas Mallempati, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1801 Gadsden Hwy, Birmingham, AL 35235 Phone: 205-838-3900 Fax: 205-838-3906 | |
Elizabeth Chantal Twist, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 | |
Leesa D Miles, RPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2500 4th Ave S, Birmingham, AL 35233 Phone: 205-263-5800 Fax: 205-263-5850 |